10 spots left to join us for the Digiday Publishing Summit

Join us Sept. 14-16 in Miami to connect with top publishing leaders

SECURE YOUR SEAT

Mushroom boardroom: Why some execs are using psychedelics to get through the workday

work overload gif

This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.

After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.

Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.

More in Marketing

OpenAI’s ads business hits Europe at the six month mark

OpenAI will begin serving ads to people using ChatGPT across 31 European markets beginning August 24.

Divine, Vine’s spiritual successor, won’t rule out ads

The app has a strict ‘no AI content’ rule, and company isn’t ruling out advertising.

OpenAI builds offerings on consent as it expands ChatGPT ads to Europe

The company’s new EU privacy policy goes live “later this month”.